a-Synuclein and lipids in erythrocytes of Gaucher disease carriers and patients before and after enzyme replacement therapy.
It is well established that patients with Gaucher disease, as well as carriers of the disease have an increased risk for developing Parkinson's disease. A plethora of evidence suggests that disturbed α-Synuclein homeostasis is the link between Gaucher disease and Parkinson's disease. The p...
Main Authors: | Marina Moraitou, Georgios Sotiroudis, Nikolaos Papagiannakis, Maria M J Ferraz, Aristotelis Xenakis, Johannes M F G Aerts, Leonidas Stefanis, Helen Michelakakis |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2023-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0277602 |
Similar Items
-
a-Synuclein and lipids in erythrocytes of Gaucher disease carriers and patients before and after enzyme replacement therapy
by: Marina Moraitou, et al.
Published: (2023-01-01) -
A novel mutation deep within intron 7 of the GBA gene causes Gaucher disease
by: Anna Malekkou, et al.
Published: (2020-03-01) -
Alpha-Synuclein mRNA Level Found Dependent on L444P Variant in Carriers and Gaucher Disease Patients on Enzyme Replacement Therapy
by: Paweł Dubiela, et al.
Published: (2023-04-01) -
Phagocytosis of Erythrocytes from Gaucher Patients Induces Phenotypic Modifications in Macrophages, Driving Them toward Gaucher Cells
by: Lucie Dupuis, et al.
Published: (2022-07-01) -
Patient centered guidelines for the laboratory diagnosis of Gaucher disease type 1
by: A. Dardis, et al.
Published: (2022-12-01)